Madrigal Pharmaceuticals Inc

NASDAQ:MDGL   4:00:00 PM EDT
302.64
+1.89 (+0.63%)
: $303.00 +0.36 (+0.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.76B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$158.12 Million
Adjusted EPS-$3.57
See more estimates
10-Day MA$293.45
50-Day MA$293.41
200-Day MA$296.11
See more pivots

Madrigal Pharmaceuticals Inc Stock, NASDAQ:MDGL

200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428
United States of America
Phone: +1.267.824.2827
Number of Employees: 528

Description

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.